or Try an Advanced Search...

    Technical Analysis for QTTB - Q32 Bio Inc.

    Grade Last Price % Change Price Change
    F 27.10 -0.66% -0.18
    QTTB closed down 6.22 percent on Wednesday, November 20, 2024, on 1.43 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical QTTB trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -0.66%
    Multiple of Ten Bearish Other -0.66%
    Wide Bands Range Expansion -0.66%
    Below Lower BB Weakness -0.66%
    Down 3 Days in a Row Weakness -0.66%
    Down 4 Days in a Row Weakness -0.66%
    Down 5 Days in a Row Weakness -0.66%
    Lower Bollinger Band Touch Weakness -0.66%
    Oversold Stochastic Weakness -0.66%
    Fell Below 200 DMA Bearish -6.84%
    Older End-of-Day Signals for QTTB ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 2 hours ago
    Down 3% about 2 hours ago
    Up 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    QTTB Chart by TradingView
    Basic chart:

    Profile

    Q32 Bio is a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. Q32 Bio's lead programs, focused on the IL-7 / TSLP receptor pathways and complement system, address immune dysregulation to help patients take back control of their lives.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Immunology Immune System Autoimmunity Autoimmune And Inflammatory Disease Complement System Thymic Stromal Lymphopoietin

    Is QTTB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 Q32 Bio GAAP EPS of -$1.46
    Nov 7 Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 5 Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
    Oct 14 Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
    Aug 29 Q32 Bio to Participate in Upcoming September Investor Conferences
    Aug 29 Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097
    Aug 8 Q32 Bio GAAP EPS of -$1.42
    Jul 31 Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
    Jul 9 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis
    Jul 1 Q32 Bio to join Russell 3000 Index
    See more QTTB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.79
    52 Week Low 9.18
    Average Volume 99,827
    200-Day Moving Average 30.29
    50-Day Moving Average 44.74
    20-Day Moving Average 42.66
    10-Day Moving Average 37.75
    Average True Range 3.84
    RSI (14) 18.70
    ADX 28.3
    +DI 10.84
    -DI 35.05
    Chandelier Exit (Long, 3 ATRs) 41.65
    Chandelier Exit (Short, 3 ATRs) 37.52
    Upper Bollinger Bands 56.73
    Lower Bollinger Band 28.59
    Percent B (%b) -0.05
    BandWidth 65.95
    MACD Line -4.19
    MACD Signal Line -2.03
    MACD Histogram -2.1631
    Fundamentals Value
    Market Cap 1.58 Billion
    Num Shares 58 Million
    EPS -2.28
    Price-to-Earnings (P/E) Ratio -11.96
    Price-to-Sales 20.76
    Price-to-Book 0.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 33.43
    Resistance 3 (R3) 33.69 31.89 32.41
    Resistance 2 (R2) 31.89 30.33 31.77 32.06
    Resistance 1 (R1) 29.59 29.36 28.69 29.33 31.72
    Pivot Point 27.79 27.79 27.35 27.67 27.79
    Support 1 (S1) 25.49 26.23 24.59 25.23 22.84
    Support 2 (S2) 23.69 25.26 23.57 22.50
    Support 3 (S3) 21.39 23.69 22.16
    Support 4 (S4) 21.13